180 related articles for article (PubMed ID: 3487240)
21. Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium.
Buxton DB; Mody FV; Krivokapich J; Phelps ME; Schelbert HR
Circulation; 1992 May; 85(5):1842-56. PubMed ID: 1572040
[TBL] [Abstract][Full Text] [Related]
22. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.
Brown M; Marshall DR; Sobel BE; Bergmann SR
Circulation; 1987 Sep; 76(3):687-96. PubMed ID: 3113765
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhibition of fatty acid oxidation on myocardial kinetics of 11C-labeled palmitate.
Wyns W; Schwaiger M; Huang SC; Buxton DB; Hansen H; Selin C; Keen R; Phelps ME; Schelbert HR
Circ Res; 1989 Dec; 65(6):1787-97. PubMed ID: 2684448
[TBL] [Abstract][Full Text] [Related]
24. Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate.
Lerch RA; Bergmann SR; Ambos HD; Welch MJ; Ter-Pogossian MM; Sobel BE
Circulation; 1982 Apr; 65(4):731-8. PubMed ID: 7060253
[No Abstract] [Full Text] [Related]
25. Assessment of myocardial fatty acid metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Torizuka T; Nohara R; Kambara H; Konishi J
Am Heart J; 1993 Mar; 125(3):702-10. PubMed ID: 8438699
[TBL] [Abstract][Full Text] [Related]
26. Ketone Body Infusion With 3-Hydroxybutyrate Reduces Myocardial Glucose Uptake and Increases Blood Flow in Humans: A Positron Emission Tomography Study.
Gormsen LC; Svart M; Thomsen HH; Søndergaard E; Vendelbo MH; Christensen N; Tolbod LP; Harms HJ; Nielsen R; Wiggers H; Jessen N; Hansen J; Bøtker HE; Møller N
J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28242634
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.
Brown MA; Myears DW; Bergmann SR
J Am Coll Cardiol; 1988 Oct; 12(4):1054-63. PubMed ID: 3262128
[TBL] [Abstract][Full Text] [Related]
28. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans.
Wisneski JA; Gertz EW; Neese RA; Mayr M
J Clin Invest; 1987 Feb; 79(2):359-66. PubMed ID: 3805273
[TBL] [Abstract][Full Text] [Related]
29. Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Welch MJ; Lewis JS; Kim J; Sharp TL; Dence CS; Gropler RJ; Herrero P
J Nucl Med; 2006 Apr; 47(4):689-97. PubMed ID: 16595504
[TBL] [Abstract][Full Text] [Related]
30. Cardiac positron tomography: current status and future directions.
Geltman EM; Roberts R; Sobel BE
Herz; 1980 Apr; 5(2):107-19. PubMed ID: 6970158
[TBL] [Abstract][Full Text] [Related]
31. Interrelations in the oxidative metabolism of free fatty acids, glucose, and glycerol in normal and hyperlipemic patients. A compartmental model.
Malmendier CL; Delcroix C; Berman M
J Clin Invest; 1974 Aug; 54(2):461-76. PubMed ID: 4527190
[TBL] [Abstract][Full Text] [Related]
32. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
33. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive quantitation of regional myocardial oxygen consumption in vivo with [1-11C]acetate and dynamic positron emission tomography.
Buxton DB; Nienaber CA; Luxen A; Ratib O; Hansen H; Phelps ME; Schelbert HR
Circulation; 1989 Jan; 79(1):134-42. PubMed ID: 2783396
[TBL] [Abstract][Full Text] [Related]
35. Increased incorporation of 14C-palmitate into tissue lipids by isolated heart myocytes in endotoxic shock.
Liu MS
Adv Shock Res; 1982; 7():43-9. PubMed ID: 6753537
[TBL] [Abstract][Full Text] [Related]
36. Assessment of myocardial metabolism with 11C-palmitate. Comparison with 123I-heptadecanoic acid.
Lerch RA; Bergmann SR
Eur Heart J; 1985 Aug; 6 Suppl B():21-7. PubMed ID: 3878785
[TBL] [Abstract][Full Text] [Related]
37. Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
Knuuti J; Takala TO; Någren K; Sipilä H; Turpeinen AK; Uusitupa MI; Nuutila P
Diabetologia; 2001 Feb; 44(2):184-7. PubMed ID: 11270674
[TBL] [Abstract][Full Text] [Related]
38. Assessment of regional myocardial ischemia by positron-emission computed tomography.
Schelbert HR; Henze E; Phelps ME; Kuhl DE
Am Heart J; 1982 Apr; 103(4 Pt 2):588-97. PubMed ID: 6978056
[TBL] [Abstract][Full Text] [Related]
39. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography.
vom Dahl J; Herman WH; Hicks RJ; Ortiz-Alonso FJ; Lee KS; Allman KC; Wolfe ER; Kalff V; Schwaiger M
Circulation; 1993 Aug; 88(2):395-404. PubMed ID: 8339403
[TBL] [Abstract][Full Text] [Related]
40. C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium.
Schön HR; Schelbert HR; Robinson G; Najafi A; Huang SC; Hansen H; Barrio J; Kuhl DE; Phelps ME
Am Heart J; 1982 Apr; 103(4 Pt 1):532-47. PubMed ID: 6801944
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
